Coordinatore | IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
Nazionalità Coordinatore | United Kingdom [UK] |
Totale costo | 2˙937˙833 € |
EC contributo | 2˙937˙833 € |
Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | FP7-PEOPLE-2007-1-1-ITN |
Funding Scheme | MC-ITN |
Anno di inizio | 2008 |
Periodo (anno-mese-giorno) | 2008-09-01 - 2012-08-31 |
# | ||||
---|---|---|---|---|
1 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | coordinator | 0.00 |
2 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | participant | 0.00 |
3 |
EVONIK MEMBRANE EXTRACTION TECHNOLOGY LIMITED
Organization address
address: "Unit 25, Talina Centre, Bagley's Lane" contact info |
UK (LONDON) | participant | 0.00 |
4 |
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
Organization address
address: Great West Road contact info |
UK (BRENTFORD) | participant | 0.00 |
5 |
HOVIONE FARMACIENCIA SA
Organization address
address: SETE CASAS contact info |
PT (LOURES) | participant | 0.00 |
6 |
LONZA AG
Organization address
address: Muenchensteinerstrasse 38 contact info |
CH (BASEL) | participant | 0.00 |
7 |
MIP TECHNOLOGIES AB
Organization address
address: Research Park Ideon contact info |
SE (LUND) | participant | 0.00 |
8 |
TECHNISCHE UNIVERSITAT DORTMUND
Organization address
address: AUGUST SCHMIDT STRASSE 4 contact info |
DE (DORTMUND) | participant | 0.00 |
9 |
UCB PHARMA SA
Organization address
address: ALLEE DE LA RECHERCHE 60 contact info |
BE (BRUXELLES) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The NEMOPUR Initial Training Network will focus on creating a new generation of molecular purification technologies for Active Pharmaceutical Ingredient (API) manufacture, with a particular focus on removal of organic impurities from API production. New membranes with improved chemical stability in a wide range of solvents, and better controlled cutoff properties, novel molecularly imprinted polymers with readily scalable production chemistries, and composite molecularly imprinted film – macroporous support membranes will be developed. The applications of these technologies will be through the industrial partners. The project is multidisciplinary, involving chemists, materials scientists and chemical engineers. The consortium is intersectorial, comprising 3 universities/research institutes, 2 technology SMEs and 4 pharmaceutical manufacturers, and will have a strong emphasis on knowledge creation, technology commercialisation, and entrepreneurship. The training programme involves Early Stage Researchers (ESR), at both university and industrial partners, each of whom will complete a PhD thesis through a combination of local and network wide research experience. Experienced Researchers (ER) will complete their training, focussing on knowledge transfer, commercialisation and entreprenuership skills. In addition to their individual research, ESR and ER will complete complementary training through a series of Personal Skills Modules, and a course on Technology Commercialisation and Entrepreurship. NEMOPUR seeks to contribute to improving the European knowledge supply chain through this industry-academia programme of applied research aimed at developing engineers and scientists who are academically excellent and achieve PhD degrees, but who thrive at the interface between fundamental research and industrial application.'